Rani Therapeutics
RANI
RANI
32 hedge funds and large institutions have $30.4M invested in Rani Therapeutics in 2022 Q3 according to their latest regulatory filings, with 7 funds opening new positions, 9 increasing their positions, 8 reducing their positions, and 2 closing their positions.
New
Increased
Maintained
Reduced
Closed
more first-time investments, than exits
New positions opened: | Existing positions closed:
more funds holding
Funds holding: →
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more ownership
Funds ownership: →
5% more capital invested
Capital invested by funds: $29.1M → $30.4M (+$1.31M)
0% more funds holding in top 10
Funds holding in top 10: 2 → 2 (0)
Holders
32
Holding in Top 10
2
Calls
$2K
Puts
–
Top Buyers
| 1 | +$3.04M | |
| 2 | +$461K | |
| 3 | +$202K | |
| 4 |
LI
Lafayette Investments
Ashton,
Maryland
|
+$191K |
| 5 |
ISB
Iowa State Bank
Urbandale,
Iowa
|
+$181K |
Top Sellers
| 1 | -$227K | |
| 2 | -$217K | |
| 3 | -$196K | |
| 4 |
Wells Fargo
San Francisco,
California
|
-$183K |
| 5 |
Goldman Sachs
New York
|
-$111K |